Marker useful for detection and measurement of free radical...

Details Marker useful for detection and measurement of free radical... Marker useful for detection and measurement of free radical...

2006-07-04

2006-07-04

Swartz, Rodney P (Department: 1645)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C435S017000, C435S007920

Reexamination Certificate

active

07070937

ABSTRACT:
The present invention teaches a marker useful for detection and measurement of free radical damage. Specifically, the invention takes advantage of alterations which occur to the N-terminus of the albumin molecule, a circulating protein in human blood, in the presence of free radicals. These alterations effect the ability of the N-terminus of the albumin molecule to bind metals. Methods for detecting and quantifying this alteration include evaluating and quantifying the cobalt binding capacity of an albumin-containing sample, analysis and measurement of the ability of albumin to bind exogenous cobalt, detection and measurement of the presence of copper in a purified albumin sample and use of an immunological assay specific to the altered form of serum albumin which occurs following free radical damage. Also taught by the present invention is the use of the peptide Asp Ala His Lys and the compound Asp-Ala-His-Lys-R, wherein R is any chemical group capable of producing a detectable signal when a metal ion capable of binding to the N-terminus of naturally-occurring albumin is bound to the compound, for detection and quantitation of the marker. Methods of the present invention also include use of the marker as a “biochemical tag,” thereby allowing for sensitive detection and measurement of the efficacy of clinical drugs and therapeutics which result in the generation of free radicals or which act to limit free radical damage. The marker also acts as a “biological tag” of a process implicated in a wide array of diseases and conditions and, accordingly, may be used to monitor and assess such diseases and conditions. Finally, the invention provides antibodies, immunoassays, and kits for use in detecting or quantitating the marker.

REFERENCES:
patent: 3955926 (1976-05-01), Fischer
patent: 4230601 (1980-10-01), Hill
patent: 4337064 (1982-06-01), Gindler
patent: 4379848 (1983-04-01), Yeaw
patent: 4434234 (1984-02-01), Adams et al.
patent: 4468466 (1984-08-01), Morrissey
patent: 4486282 (1984-12-01), Bier
patent: 4492753 (1985-01-01), Shell et al.
patent: 4510383 (1985-04-01), Ruppender
patent: 4568647 (1986-02-01), Sanford
patent: 4569794 (1986-02-01), Smith et al.
patent: 4592893 (1986-06-01), Poppe et al.
patent: 4713327 (1987-12-01), Findlay et al.
patent: 4786605 (1988-11-01), Mauck et al.
patent: 4960710 (1990-10-01), Lau
patent: 5077222 (1991-12-01), Lau
patent: 5141855 (1992-08-01), Schmittou
patent: 5169936 (1992-12-01), Staples et al.
patent: 5173422 (1992-12-01), Knowles et al.
patent: 5173431 (1992-12-01), Pugia et al.
patent: 5182214 (1993-01-01), Kessler et al.
patent: 5223392 (1993-06-01), Cohen
patent: 5225354 (1993-07-01), Knowles et al.
patent: 5227307 (1993-07-01), Bar-Or et al.
patent: 5290519 (1994-03-01), Bar-Or et al.
patent: 5290678 (1994-03-01), Jackowski
patent: 5326707 (1994-07-01), Franke et al.
patent: 5503987 (1996-04-01), Wagner et al.
patent: 5532136 (1996-07-01), Carlson et al.
patent: 5569608 (1996-10-01), Sommer
patent: 5604105 (1997-02-01), Jackowski
patent: 5620856 (1997-04-01), Carlson et al.
patent: 5639624 (1997-06-01), Wagner et al.
patent: 5654160 (1997-08-01), Johnson
patent: 5656729 (1997-08-01), Fuluhata et al.
patent: 5670627 (1997-09-01), Johnson
patent: 5670645 (1997-09-01), Johnson
patent: 5683907 (1997-11-01), Johnson
patent: 5710008 (1998-01-01), Jackowski
patent: 5744358 (1998-04-01), Jackowski
patent: 5747274 (1998-05-01), Jackowski
patent: 5876969 (1999-03-01), Fleer et al.
patent: 5994339 (1999-11-01), Crapo et al.
patent: 6020204 (2000-02-01), DerVartanian et al.
patent: 6083758 (2000-07-01), Imperiali et al.
patent: 6087184 (2000-07-01), Magginetti et al.
patent: 6171870 (2001-01-01), Freitag
patent: 6235489 (2001-05-01), Jackowski
patent: 6268223 (2001-07-01), Cornell-Bell et al.
patent: 6274305 (2001-08-01), Sonnenschein et al.
patent: 6335205 (2002-01-01), Bausback
patent: 6375930 (2002-04-01), Young et al.
patent: 6410341 (2002-06-01), Freitag et al.
patent: 6444432 (2002-09-01), Kleinfeld
patent: 6767708 (2004-07-01), Williams et al.
patent: 2003/0017506 (2003-01-01), Bar-Or et al.
patent: 2004/0175754 (2004-09-01), Bar-Or et al.
patent: 2004/0209379 (2004-10-01), Bar-Or et al.
patent: WO 00/20454 (2000-04-01), None
patent: WO 00/20840 (2000-04-01), None
patent: WO 00/52476 (2000-09-01), None
patent: WO 04/030522 (2004-04-01), None
Ames et al.,Proc. Natl. Acad. Sci. USA, 90:7915-7922 (1993).
Florence,Australian and New Zealand J. Opthamol., 23(1):3-7 (1995).
Halliwell and Gutteridge, “Free Radicals in Biology and Medicine” pp. 1-21 (2nd ed. Clarendon Press—Oxford 1989).
Henderson's Dictionary of Biological Terms, 10th ed. Eleanor Lawrence, ed., John Wiley & Sons, NY, p. 252.
Kerr et al., Introduction to Oxygen Free Radicals,Heart&Lung, 25, 200-209 (1996).
Knight, Diseases Related to Oxygen-Derived Free Radicals,Ann of Clin.Lab Sci., 25, 111-121 (1995).
Lakusta et al. (1979)Journal of Inorganic Biochemistry11:303-315.
Malins et al.,Proc. Natl. Acad. Sci USA, 93:2557-2565 (1996).
Manso, Ischemia, Reperfusion and Oxygen Free Radicals,Rev. Port. Cardiol., 11, 997-999 (1992).
Mohanakrishnan et al. (1982)Journal of Pharmaceutical Sciences, 71(10):1180-1182.
Pratico D. et al., “Localization of distinct F2-isoprostanes in human atherosclerotic lesions,”J. Clin. Invest.100(8):2028-2034 (1997).
Smith et al., Cytochemical Demonstration of Oxidative Damage in Alzheimer Disease by Immunochemical Enhancement . . .Journal of Histochem&Cytochem., 46:731-735 (1998).
Ueda et al.,J. Inorgan. Biochem., 55:123-130 (1994).
Bar-Or et al., 2002,Free Rad. Biol&Med., 32(2):197—1991.
Bar-Or et al., 2001,Am. Heart J., 141(6):986-991.
Bar-Or et al., 2001,Eur. J. Biochem, 268:42-47.
Bar-Or et al., 2000,J. Emergency Med., 19(4):311-315.
Bar-Or et al., 1999,Ann Emergency Med., 3:Oct. 4, 1999, Part 2, S56.
U.S. Appl. No. 09/165,581, filed Oct. 2, 1998.
U.S. Appl. No. 09/165,926, filed Oct. 2, 1998.
U.S. Appl. No. 09/165,961, filed Oct. 2, 1998.
Afans'ev, Superoxide Ion: Chemistry and Biological Implications, vol. 1, pp. 26, 51, 147, 168-196, 248-266 (CRC Press, Boca Raton, FL) (1989).
Afans'ev, Superoxide Ion: Chemistry and Biological Implications, vol. II, pp. 138 and 187 (CRC Press, Boca Raton, FL) (1989).
Alberts et al.,Mol. Biol. Cell, (2nd ed., Garland Publishing Inc. 1989).
Anderson, “Effects of na+k=2cl Cotransport Inhibition on Myocardial NA and CA During Ischemia and Reperfusion,” found at http://www.uth.tmc.ed/apstracts/1995/cell/September/319c.html, p. 1 (Sep. 1995), published in APStracts on Sep. 23, 1995.
Bautista et al.,Biosci. Biotechnol. Biochem., 62(3):419-423 (1998).
Boehringer Mannheim Catalog No. 15947.
Braughler, “Calicum and Lipid Peroxidation,” from Central Nervous System Diseases Research Unit, p. 99 (1987), The Upjohn Company, Kalamazoo, Michigan.
Chan,Eur. J. Biochem., 227:524-528 (1995).
Cobbe,J. Mol. Cell. Card., 12:745-760 (1980).
Cotelle et al.,J. Inorganic Biochem., 46:7-15 (1992).
“DNA Damage Linked to Risk of Breast Cancer Spread,” found at http://www.pslgroup.com/dg/6c2e.htm.
Das et al.,Meth. Enzymol., 233:601-610 (1994).
Davies,J. Free Radicals Biol.&Med., 2:155-173 (1986).
Davies, “Oxygen Radicals Stimulate Intracellular Proteolysis and Lipid Peroxidation by Independent Mechanisms in Erythrocytes,” from the Dept. of Physiology and Biophysics, Harvard Medical School,J. Biol. Chem., vol. 262, No. 17, issue of Jun. 15, pp. 8220-8225, (1987), Boston Massachusetts.
Davies et al.,J. Biological Chem., 262(20):9895-9901 (1987).
Davies et al.,J. Biological Chem., 262(20):9902-9907 (1987).
Davies et al.,J. Biological Chem., 262(20):9908-9913 (1987).
Davies et al.,J. Biological Chem., 262(20):9914-9920 (1987).
Dolovich et al.,Br. J Ind Med, 41:51-55 (1984).
Fleming and Nixon,Analytical Biochem, 154:691-701 (1986).
Genest et al.,J Am Coll Cardiol, 16:1114-9 (1990).
Gobel et al.,Eur. Heart J., 19:1208-1213 (1998).
Gomez, “Ruling Out Ischemia Saves Time and Money,” vol. 6(9)

Affiliated with

Also associated with

Rating

Marker useful for detection and measurement of free radical... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Marker useful for detection and measurement of free radical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Marker useful for detection and measurement of free radical... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3556680